Acquisition Integration EndoVantage was acquired by RapidAI, creating opportunities to cross-sell its case-specific endovascular planning tools to RapidAI’s stroke imaging customers and to integrate planning workflows with existing imaging platforms.

Hospital Market Opportunity The platform enables clinicians to evaluate multiple endovascular devices and design personalized treatment strategies with cost comparisons, making it attractive to hospital vascular programs seeking value-based care and procurement optimization.

On Premise Deployability With a Linux, C/C++, and OpenMP stack, EndoVantage can be deployed in hospital on premise environments or private HPC, addressing data security concerns and enabling tighter IT integration for adoption.

Pilot & ROI Focus Because revenue is modest and the product targets workflow improvement and device cost optimization, pursuing pilot deployments with vascular surgery teams can demonstrate return on investment and accelerate licensing.

Strategic Partnerships Opportunity to partner with large medical device manufacturers, health IT integrators, or imaging platforms to broaden reach, co-market solutions, and embed EndoVantage planning capabilities within broader endovascular care offerings.